Evolent Health Files 8-K on Financials

Ticker: EVH · Form: 8-K · Filed: Feb 20, 2025 · CIK: 1628908

Sentiment: neutral

Topics: financial-condition, results-of-operations, filing

Related Tickers: EVH

TL;DR

EVH filed an 8-K detailing financials. Check it out.

AI Summary

Evolent Health, Inc. filed an 8-K on February 20, 2025, reporting on its financial condition and results of operations. The filing includes financial statements and exhibits, with the company's principal executive offices located at 1812 N. Moore Street, Suite 1705, Arlington, Virginia.

Why It Matters

This filing provides investors with crucial updates on Evolent Health's financial performance and condition, which can influence investment decisions.

Risk Assessment

Risk Level: low — This is a routine financial filing and does not appear to contain any new material risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on Evolent Health, Inc.'s Results of Operations and Financial Condition, and to include Financial Statements and Exhibits.

When was this 8-K report filed?

This 8-K report was filed on February 20, 2025.

Where are Evolent Health, Inc.'s principal executive offices located?

Evolent Health, Inc.'s principal executive offices are located at 1812 N. Moore Street, Suite 1705, Arlington, Virginia.

What is the Commission File Number for Evolent Health, Inc.?

The Commission File Number for Evolent Health, Inc. is 001-37415.

What is the I.R.S. Employer Identification Number for Evolent Health, Inc.?

The I.R.S. Employer Identification Number for Evolent Health, Inc. is 32-0454912.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on February 20, 2025 regarding Evolent Health, Inc. (EVH).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing